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Abstract
Background: Instillation of highly soluble nanoparticles (NPs) into the lungs of rodents can cause acute
eosinophilia without any previous sensitizations by the role of dissolved ions. However, whether gradually
dissolving NPs can cause the same type of eosinophilia remains to be elucidated. We selected nickel oxide (NiO) as
a gradually dissolving NP and evaluated the time course pulmonary inflammation pattern as well as its
mechanisms.
Methods: NiO NPs were intratracheally instilled into female Wistar rats at various concentrations (50, 100, and
200 cm2/rat) and the lung inflammation was evaluated at various time-points (1, 2, 3, and 4 days). As positive
controls, NiCl2 and the ovalbumin-induced allergic airway inflammation model was applied. NiCl2 was instilled at
171.1 μg Ni/rat, which is equivalent nickel concentration of 200 cm2/rat of NiO NPs. Cytological analysis and
biochemical analysis including lactate dehydrogenase (LDH), total protein, and pro-inflammatory cytokines were
measured in bronchoalveolar lavage fluid (BALF). The levels of total immunoglobulin E (IgE) and anaphylatoxins
(C3a and C5a) were measured in BALF and serum. The levels of eotaxin were measured in the alveolar
macrophages and normal lung tissue before and after addition of cell lysis buffer to evaluate whether the direct
lysis of cells can release intracellular eotaxin.
Results: NiO NPs produced acute neutrophilic inflammation throughout the study. However, eosinophils were
recruited at 3 and 4 days post-instillation of NiO NPs and the magnitude and pattern of inflammation was similar
with NiCl2 at 24 h post-instillation. The eosinophil recruitment by NiO NPs was not related with either the levels of
total IgE or anaphylatoxins. The lysis of alveolar macrophages and normal lung tissue showed high levels of
intracellular eotaxin and the levels of LDH showed positive correlation with the levels of eotaxin.
Conclusions: Instillation of NiO NPs produced neutrophilia at 1 and 2 days after instillation, while the mixed type of
neutrophilic and eosinophilic inflammation was produced at 3 and 4 days post-instillation, which was consistent
with NiCl2. The mechanism of the eosinophilia involves the direct release of intracellular eotaxin due to the rupture
of cells by the accumulated solubilized nickel ions in the phagolysosome.
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Background
Several mechanisms have been known to cause eosino-
philic inflammation including the immunoglobulin E
(IgE)-mediated allergic response as well as anaphylatox-
ins by the complement activation cascade. IgE-mediated
eosinophilia, commonly known as an allergic reaction,
can be produced by an immunological response syn-
chronized by several sensitization processes against a
certain allergen [1] or parasite infection [2]. The activa-
tion of complement releases anaphylatoxins (e.g., C3a
and C5a) and produces eosinophilia by histamine release
from mast cells. This type of inflammation is generally
called as pseudoallergy or drug hypersensitivity [3]. In
our recent studies, however, some metal oxide nanopar-
ticles (NPs) were found to cause pulmonary eosinophilia
within 24 h without any previous sensitization [4]. Al-
though previous studies showed that instillation of TiO2
promotes allergic sensitization and lung inflammation in
the ovalbumin (OVA)-sensitization mouse model [5],
and that liposome-based NPs produced complement-
mediated hypersensitivity [6], the mechanism of eosino-
philia by metal oxide NPs (e.g., CoO, CuO, and ZnO)
within 24 h without any previous sensitization is new
finding that deserves further investigation [7–9].
Acute eosinophil infiltration caused by metal oxide
NPs has been reported with highly soluble NPs; the dis-
solved metal ions in the acidic phagolysosomes of
phagocytes play a critical role in recruiting eosinophils.
When highly soluble NPs are inhaled, NPs remain insol-
uble in the alveoli, but are dissolved soon after phagocyt-
osis, releasing their compositional ions [10]. Indeed,
several highly soluble NPs produced acute eosinophilic
airway inflammation in rodents via their soluble metal
ions [7, 9]. The molecular mechanism of eosinophilia by
NPs involves the direct induction of the eotaxin protein;
however, the signaling pathway for eotaxin gene expres-
sion is still poorly understood [11]. Furthermore, other
possible mechanisms for eosinophil infiltration by metal
oxide NPs (e.g., IgE-mediated or anaphylatoxins by com-
plement activation) are still in question.
Solubility is one of the key issues in triggering the eo-
sinophilic inflammation of metal oxide NPs. All NPs
known to produce eosinophilia in the lung are highly
soluble NPs (e.g., CoO, CuO, and ZnO), but whether
gradually dissolving NPs can produce eosinophilia is not
known. Therefore, follow-on our previous study, we hy-
pothesized, in this study, that gradually dissolving NPs
can produce pulmonary eosinophilia by accumulating
solubilized ions in phagocytes with a delayed time frame
as compared with highly soluble NPs. We selected NiO
NPs as a representative gradually dissolving NP based
on our previous study [12], and investigated the time
course of inflammation and its underlying mechanism
using a rat intratracheal instillation model.
Results
Physicochemical characterization of NiO NPs
Physicochemical properties of NiO NPs are summarized
in Table 1. Transmission electron microscopy (TEM)
and field emission-type scanning electron microscopy
(FE-SEM) analysis showed that NiO NPs were spheric-
ally shaped and the average diameter of NiO NPs was
about 5.3 nm (Figure S1, see Additional file 1). NiO NPs
formed large agglomerates when dispersed in phosphate
buffered saline (PBS). However, 3 % rat serum improved
the dispersion, such that it became similar to that of in
distilled water (DW). The zeta potential of NiO NPs was
positive in DW, but negative in PBS or PBS with 3 % rat
serum. NiO NPs showed 9.5 % and 1.1 % dissolution
within 24 h in artificial lysosomal fluid and PBS, respect-
ively. Incubation of NiO NPs in PBS with 3 % rat serum
showed about 2.2 % dissolution, which was slightly
higher than that of without serum. NiO NPs showed no
endotoxin contamination.
Pulmonary inflammation pattern evaluated by differential
cell counts of BALF
To evaluate the time-course inflammation pattern of
NiO NPs, single intratracheal instillation was performed
at concentrations of 50, 100, and 200 cm2/rat which cor-
responding 54.5, 109, and 218 μg/rat in a mass basis and
the type and magnitude of lung inflammation was evalu-
ated at various time-points. As a positive control for
Table 1 Physicochemical characterization of NiO NPs
Measurements Mean ± SEM
Primary size (nm) 5.3 ± 0.4
Surface area (m2/g) 91.8
Hydrodynamic size (nm) in
DW 209 ± 3.7
PBS 970 ± 52
PBS with 3 % rat serum 224 ± 11
Polydispersity in
DW 0.30 ± 0.02
PBS 0.65 ± 0.05
PBS with 3 % rat serum 0.45 ± 0.06
Zeta potential (mV) in
DW 48.9 ± 0.6
PBS −21 ± 0.6
PBS with 3 % rat serum −30 ± 2.3
Solubility (%) in
PBS (pH 7.4) 1.1
PBS with 3 % rat serum 2.2
Artificial lysosomal fluid (pH 5.5) 9.5
Endotoxin <0.1 EU/mL
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dissolved nickel ions, NiCl2 was instilled at 171.1 μg Ni/
rat, which is equivalent nickel concentration of 200 cm2/
rat of NiO NPs. The OVA-induced airway inflammation
model was established as a positive control for IgE-
mediated eosinophilic inflammation. To confirm that
the unique inflammation pattern by NiO NPs is not just
a coincidence, 10 rats per group were used for the evalu-
ation of time-course inflammation of NiO NPs at
200 cm2/rat, while other experiments were performed
with 4 rats per group. Data for the cytological analysis of
bronchoalveolar lavage fluid (BALF) is presented in
Fig. 1. NiO NPs (200 cm2/rat) at 4 days after instillation
showed higher number of total cells, macrophages, and
neutrophils compared to other time-points which might
be due to the continuous stimulation by NPs as well as
dissolved ions. This worsening inflammation pattern is
also consistent with the cytological data of NiO NPs at
50 and 100 cm2/rat (Figure S2, see Additional file 1). Al-
though the numbers of inflammatory cells showed statis-
tical significance compared to vehicle control, the values
were much less than those of 200 cm2/rats. While, NiO
NPs at 200 cm2/rat significantly increased the number of
neutrophils at all time points, ranging from about 30 to
50 % of total cells. The number of eosinophils signifi-
cantly increased at 3 days after instillation that was
about 5.5 % of total cells. The lymphocytes in BALF
showed no significant increases and the percentage of
lymphocytes was less than 0.5 % and basophils were not
observed in any treatment groups (data not shown). The
type and magnitude of inflammation by NiCl2 at 24 h
after instillation were very similar to that of high dose
group of NiO NPs at 3 and 4 days after instillation. The
OVA-induced airway inflammation model showed sig-
nificant increases in the number of neutrophils and eo-
sinophils in BALF at 24 h after challenge.
Levels of Ni in BALF
The levels of Ni in BALF of 200 cm2/rat of NiO NPs
showed significant increases at all time-points (Figure
S3, see Additional file 1). The levels of Ni were peaked
Fig. 1 Cytological analysis of BALF after intratracheal instillation of NiO NPs, NiCl2, and OVA. NiO NPs were instilled at 200 cm
2/rat and cytological
evaluation was performed at 1, 2, 3, and 4 days after instillation. NiCl2 was instilled at 378.0 μg/rat, which is equivalent to the nickel dose
(171.1 μg Ni/rat) of NiO NPs at 200 cm2/rat, and cytological evaluation was performed at 1 day after instillation. a, Number of total cells. b
Number of macrophages. c Number of neutrophils. d Number of eosinophils. Abbreviations: VEH, vehicle control for NiO NPs and NiCl2; OVA,
ovalbumin-induced allergic airway inflammation; VEHOVA, vehicle control for OVA group. Mean ± SEM (n = 10 for NiO NPs and n = 4 for NiCl2 and
OVA group). One-way ANOVA test was applied for comparison between NiO NPs and VEH with statistical significance indicated by *p < 0.05,
**p < 0.01, and ***p < 0.001. Student’s t-test was applied for comparison of NiCl2 against VEH and OVA group against VEHOVA with statistical
significance indicated by ##p < 0.01 and ###p < 0.001
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at 1 or 2 days after instillation and showed slightly de-
creasing trend thereafter.
Levels of lactate dehydrogenase (LDH) and total protein
in BALF
The levels of LDH and total protein at 200 cm2/rat of
NiO NPs were significant increased 2–4 days after instil-
lation (Fig. 2). The levels of LDH and total protein at 50
and 100 cm2/rat of NiO NPs were increased with dose-
dependent and time-dependent manner (Figure S4, see
Additional file 1). Although significant increases were
found at 50 and 100 cm2/rats, these values were much
less than those of 200 cm2/rats. Instillation of NiCl2 pro-
duced similar magnitude of increases in the levels of
LDH and total protein of 200 cm2/rat of NiO NPs at 3
and 4 days after instillation (Fig. 2). The OVA-sensitized
group showed significant increases in the levels of LDH
and total protein; however, the magnitude of the in-
crease was much smaller than that produced by the high
dose of NiO NPs (Fig. 2).
Expression of pro-inflammatory cytokines in BALF
Data for pro-inflammatory cytokines in BALF is pre-
sented in Fig. 3. The concentrations of interleukin (IL)-
1β were not significantly increased at any time points,
while the levels of cytokine-induced neutrophil
chemoattractant-3 (CINC-3) significantly increased at
1 day after instillation of NiO NPs at 200 cm2/rat. The
concentrations of eotaxin significantly increased at 3 days
after instillation of NiO NPs at 200 cm2/rat. However,
the levels of IL-4 and interferon-γ (IFN-γ) in the BALF
of any treatment group were below the detection limit
(15.6 pg/mL for IL-4 and 39.1 pg/mL for IFN-γ) (data
not shown). Instillation of NiCl2 produced significant in-
creases of the levels of CINC-3 and eotaxin, while the
levels of IL-4 and IFN-γ were below the detection limit
(data not shown). OVA-sensitized rats showed no sig-
nificant increases in IL-1β, IL-4, CINC-3, IFN-γ, and
eotaxin (data not shown for IL-4 and IFN-γ).
Levels of total IgE and anaphylatoxins (C3a and C5a) in
serum and BALF
The levels of total IgE and anaphylatoxins (C3a and
C5a) were measured because these molecules underlie
typical mechanisms for eosinophil recruitment. The
levels of total IgE in serum significantly increased only
in the OVA-sensitization group, while other groups
showed no significant changes in serum or BALF (Fig. 4).
The levels of C5a in any treatment group including the
OVA-sensitization group showed no significant changes
as compared to the vehicle control (Fig. 4). The levels of
C3a in all treatment groups was the under the detection
limit (0.625 ng/mL) (data not shown).
Levels of intracellular eotaxin in alveolar macrophages
and normal lung tissue
To evaluate the mechanism of eotaxin release by NiO
NPs, the levels of intracellular eotaxin were measured in
alveolar macrophages and normal lung tissue. Lysis of
1 × 107 alveolar macrophages using 1 mL of undiluted
cell lysis buffer produced about 100 pg/mL of eotaxin
and serial dilution of cell lysis buffer showed a good
dose–response (Fig. 5a). Lysis of 50 mg of normal lung
tissue using 1 mL of undiluted cell lysis buffer produced
Fig. 2 Levels of lactate dehydrogenase (LDH) and total protein in BALF treated with NiO NPs, NiCl2, and OVA. NiO NPs were instilled at 200 cm
2/
rat and cytological evaluation was performed at 1, 2, 3, and 4 days after instillation. NiCl2 was instilled at 378.0 μg/rat, which is equivalent to the
nickel dose (171.1 μg Ni/rat) of NiO NPs at 200 cm2/rat, and cytological evaluation was performed at 1 day after instillation. a Levels of LDH. b,
Levels of total protein. Abbreviations: VEH, vehicle control for NiO NPs and NiCl2; OVA, ovalbumin-induced allergic airway inflammation; VEHOVA,
vehicle control for OVA group. Mean ± SEM (n = 10 for NiO NPs and n = 4 for NiCl2 and OVA group). One-way ANOVA test was applied for
comparison between NiO NPs and VEH with statistical significance indicated by **p < 0.01 and ***p < 0.001. Student’s t-test was applied for
comparison of NiCl2 against VEH and OVA group against VEHOVA with statistical significance indicated by
##p < 0.01 and ###p < 0.001
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about 350 pg/mL of eotaxin and serial dilution of lysis
buffer showed a good dose–response (Fig. 5b). The de-
tected eotaxin was considered intracellular eotaxin be-
cause cells or tissues before lysis demonstrated minimal
levels of eotaxin.
Positive correlation between levels of LDH and eotaxin
To evaluate the role of intracellular eotaxin by direct
rupture of cells on acute eosinophilic inflammation, the
levels of LDH in alveolar macrophages or normal lung
tissue after incubation with lysis buffer were plotted
against the levels of eotaxin measured in the same sam-
ple. The levels of LDH, the marker for cytotoxicity,
showed positive correlation with the levels of eotaxin in
alveolar macrophages as well as in normal lung tissue
(Fig. 6). The Pearson correlation test in alveolar macro-
phages showed better correlation coefficient (r2 = 0.887,
p < 0.001) than that of normal lung tissue (r2 = 0.410, p
< 0.01).
Discussion
To our knowledge, NiO NPs are gradually dissolving
NPs that release a significant amount of nickel ions into
the lysosomes of phagocytes and require more than
1 month for complete dissolution [12]. Previous studies
on the pulmonary exposure of NiO NPs reported that
NiO NPs in the lung produced acute neutrophilic in-
flammation via surface reactivity such as the generation
of reactive oxygen species (ROS) [13, 14], while chronic
active pulmonary inflammation with immunological T
helper type 1 (Th1-type) hypersensitivity was produced
by the chronic coexistence of NPs and haptenic soluble
nickel ions [12]. In this study, we found that the
instillation of NiO NPs produced massive eosinophilic
inflammation during the period of acute neutrophilic in-
flammation. The various inflammatory patterns by NiO
NPs including neutrophilia, eosinophilia, and chronic ac-
tive/Th-1 hypersensitivity is very unique and has not
been reported yet by any materials.
The eosinophilia of NiO NPs with a delayed-time
frame (3 and 4 days after instillation) and immediate
(1 day after instillation) eosinophilia by NiCl2 might pro-
vide an important clue for the mechanism of the imme-
diate eotaxin release by highly soluble NPs (e.g., CoO,
CuO, and ZnO) [7, 8]. Because eotaxin is stored in the
cytoplasm of various normal cells such as the epithelial
cell, fibroblast, and macrophage [15, 16], the lysis of
these cells can release a significant amount of eotaxin
protein. The delayed time frame of eosinophilia by NiO
NPs found in this study might be due to the delayed
rupture of cells by the accumulation of a significant
amount of nickel ions from the NiO NPs in the phagoly-
sosomes, because NiO NPs showed about 9.5 % dissol-
ution/day in the acidic artificial lysosomal fluid. The
increased levels of nickel in BALF measured in this
study also confirm the dissolved nickel ions from NiO
NPs. The role of nickel ions on recruiting eosinophils is
supported not only by the increased levels of eotaxin at
1 day after instillation of NiCl2 which observed in this
study, but also by the increased eotaxin levels of the
highly soluble NPs (CoO, CuO, and ZnO) and their
composition ions (CoCl2 and ZnCl2) at 1 day after instil-
lation in our previous studies [8, 11]. No reports about
the direct induction of eosinophilia by poorly soluble
NPs without any previous sensitizations and the correl-
ation plot of the levels of LDH, a marker for cell lysis,
Fig. 3 Pro-inflammatory cytokines in BALF after intratracheal instillation of NiO NPs, NiCl2, and OVA. NiO NPs were instilled at 200 cm
2/rat and
evaluated the expression of pro-inflammatory cytokines at 1, 2, 3, and 4 days after instillation. NiCl2 was instilled at 378.0 μg/rat, which is equivalent to
the nickel dose (171.1 μg Ni/rat) of NiO NPs at 200 cm2/rat, and pro-inflammatory cytokines were measured at 1 day after instillation. a IL-1β. b CINC-3.
c Eotaxin. Abbreviations: VEH, vehicle control for NiO NPs and NiCl2; OVA, ovalbumin-induced allergic airway inflammation; VEHOVA, vehicle control for
OVA group. Mean ± SEM (n = 10 for NiO NPs and n = 4 for NiCl2 and OVA group). One-way ANOVA test was applied for comparison between NiO NPs
and VEH with statistical significance indicated by ***p < 0.001. Student’s t-test was applied for comparison of NiCl2 against VEH and OVA group against
VEHOVA with statistical significance indicated by
###p < 0.001
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against the levels of eotaxin that was shown in this study
also confirm this hypothesis. Therefore, this study can
suggest one of main mechanisms of pulmonary eosino-
philia by metal oxide NPs is the release of intracellular
eotaxin from ruptured cells, following the accumulation
of highly toxic soluble ions.
Eotaxin-1 (CCL11), which measured in this study is a
potent chemoattractant for eosinophils and has been
suggested as a therapeutic target as well as biomarker in
various allergic diseases including asthma [17]. Eotaxin
is an eosinophil-selective chemokine and not responsible
to neutrophils and monocytes because those cells are
not expressing CCL11-specific ligands including CCR2,
CCR3, and CCR5 [18]. Eotaxin also regulates the base-
line level of eosinophils in healthy status by constitu-
tively expressing mRNA and/or protein in normal cells
such as fibroblast, epithelial cells, endothelial cells, T
cells, and macrophages [19–21]. Among various cell
types, eosinophils possess much higher amount of
eotaxin in matrix of crystalloid granules and release
eotaxin by the activation of eosinophils [21]. Therefore,
the eosinophilia by NiO NPs found in this study might
be firstly triggered by the directly released intracellular
eotaxin by the rupture of phagocytic cells and then re-
cruited eosinophils accelerate eosinophilia. However, fur-
ther studies are needed to support this hypothetical
mechanism of action.
While the direct induction of eotaxin was shown in
this study, the involvement of IgE or complement activa-
tion by metal oxide NPs in the pulmonary eosinophilia
was unknown. Previous studies showed that various
metal oxide NPs (e.g., Fe2O3, TiO2, and ZnO) and car-
bon nanotubes have an adjuvant effect, promoting aller-
gic airway inflammation in the OVA-sensitization mouse
model [5, 22–24]. Because IgE-mediated airway inflam-
mation essentially requires an allergenic epitope and
Fig. 4 Measurement of total IgE and C5a in serum or BALF after intratracheal instillation of NiO NPs at 200 cm2/rat. Total IgE levels were
measured in (a) serum and (b) BALF. Levels of C5a were measured in (c) serum and (d) BALF. Abbreviations: VEHNP, vehicle control for NiO NPs;
OVA, ovalbumin-induced allergic airway inflammation; VEHOVA, vehicle control for OVA group. Mean ± SEM (n = 4). Student’s t-test was applied for
comparison between OVA group and vehicle control (VEHOVA) with statistical significance indicated by
###p < 0.001
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several sensitization processes, the direct induction of
IgE-response by metal oxide NPs in an acute phase with-
out previous sensitizations is highly unlikely. The lack of
significant increases in IgE and IL-4 levels in this study
also confirms that the eosinophilia by NiO NPs was not
produced by the Th2 response. However, the low levels
of eotaxin in the OVA model found in this study might
be due to the pattern of eotaxin expression is transient
[25]. The release of anaphylatoxins such as C3a and C5a
via the complement cascade can also produce acute eo-
sinophilia; previous studies showed that some micelles,
liposomes, and NPs produce an acute allergic response
[3, 26, 27]. However, those studies were performed not
in inhalation models, but in intravenous injection
models or in vitro systems using serum. No significant
changes in C3a and C5a levels found in this study might
imply that NiO NPs does not stimulate anaphylatoxins
by complement activation in this experimental setting.
However, a slightly increased levels of serum C5a at
1 day after instillation and the low group size cannot ex-
clude that some effects on C5a.
The mechanism of eosinophilia by NiO NPs at day 3
and 4 after instillation might provide important informa-
tion for the asthmatic lung disease induced by environ-
mental particles such as diesel exhaust particles and
particulate matter 2.5 (PM2.5). Indeed, several studies
showed that increased human exposure to diesel exhaust
particles and PM is related to increased asthma inci-
dence [28, 29]. However, the exact mechanism for the
development of the asthmatic lung by air pollution is
still unknown, partly because these particles are complex
and composed of multiple particle types and organic
compounds. Epidemiological data suggests that asthma
develops not only after sensitization with allergens in-
cluding food allergens [30], but also by a non-allergic
mechanism such as polycyclic aromatic hydrocarbons
Fig. 6 Correlation between LDH and eotaxin. The levels of LDH in alveolar macrophages or normal lung tissue after incubation with lysis buffer
were plotted against the levels of eotaxin measured in the same sample. a Alveolar macrophages. b Normal lung tissue. The levels of LDH
demonstrated a positive trend with the levels of eotaxin with an excellent correlation coefficient. Pearson correlation test was applied
Fig. 5 Levels of eotaxin in alveolar macrophages or normal lung tissue before/after incubation with lysis buffer. Alveolar macrophages and
normal lung tissue were incubated with different dilutions of cell lysis buffer at 1 × 107 cells/mL for alveolar macrophages and 50 mg/mL for
normal lung tissue, and the levels of eotaxin in the supernatants were measured. Lysis of (a) alveolar macrophages and (b) normal lung tissue
with undiluted cell lysis buffer showed massive increases in the levels of eotaxin and serial dilution of lysis buffer showed a good dose–response.
While samples before the addition of cell lysis buffer showed minimal levels of eotaxin. Mean ± SEM (n = 4). One-way ANOVA test was applied for
comparison of treated groups against control (samples before lysis) with statistical significance indicated by **p < 0.01 and ***p < 0.001
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[31]. Based on interesting literature on the zinc level in
the PM with a positive trend with asthma morbidity
[32], the direct induction of eotaxin protein by NiO NPs
without involvement of IgE or complement activation
can suggest one possible mechanism for this non-
allergic asthmatic lung injury by PM and further studies
are warranted.
Conclusion
Intratracheal instillation of NiO NPs in rats demon-
strated a unique mixed type of neutrophilic and eosino-
philic inflammation at 3 and 4 days after instillation,
which was consistent with the inflammation by NiCl2 at
1 day after instillation. The mechanism of eosinophilia
by NiO NPs is due to the involvement of the direct rup-
ture of cells, releasing a significant level of intracellular
eotaxin. In addition, the time frame for eosinophilia was
variable depending on the solubility of NPs and the in-
trinsic toxicity of compositional metals. However, more
studies are warranted to support this hypothetical mech-
anism of eosinophilia by metal oxide NPs.
Methods
Nanoparticles and characterization
NiO NPs were purchased from Nanostructured &
Amorphous Materials, Inc. (Houston, TX, USA). Physi-
cochemical characterization including surface area, pri-
mary size, hydrodynamic size, polydispersity, zeta
potential, solubility, and levels of endotoxin contamin-
ation were determined. Briefly, the surface area was
measuring using the BET (Brunauer, Emmett, and
Teller) method in ParticleCIC Ltd. (Leeds, UK) with a
Micromeritics TriStar 3000 analyzer (Micromeritics Ltd.,
Bedfordshire, UK). The shape and primary size of the
NiO NPs was measured using TEM (JEM-1200EX II,
JEOL, Tokyo, Japan) and FE-SEM (Hitachi, Tokyo,
Japan) and the average size was calculated by measuring
at least 200 separate particles using a built-in program
(JEOL). The hydrodynamic size and zeta potential of
NiO NPs in DW or in PBS with/without dispersion
medium (3 % heat-activated rat serum) was measured by
Zetasizer Nano-ZS (Malvern, Malvern Hill, UK) accord-
ing to the manufacturer’s instruction. To measure the
solubility of the NiO NPs, NPs were suspended in vari-
ous conditions including PBS (pH 7.4), PBS with 3 % rat
serum, and artificial lysosomal fluid (pH 5.5) [33] at
1 mg/mL and incubated for 24 h at room temperature
with continuous stirring. The NP-free supernatants were
collected by three rounds of centrifugation at 15000 g
for 30 min and the absence of NPs were confirmed by
dynamic light scattering using Zetasizer Nano-ZS (Mal-
vern). The concentration of dissolved metal ions was
measured by the Center for Collaborative Instruments at
Dong-A University using inductively coupled mass
spectrometry (ICP-MS; Agilent Technologies, Seoul,
Korea). Solubility was calculated and expressed as a per-
centage of the detected mass of nickel over the initial
mass of nickel in NiO NPs. The concentration of endo-
toxin of NiO NPs at 400 cm2/mL in sterile PBS, the
equivalent dose for animal experimentation, was evalu-
ated by an endpoint chromogenic Limulus Amoebocyte
Lysate (LAL) assay kit (Cambrex, Walkersville, MD,
USA) with a detection limit of 0.1 EU/mL.
Dispersion of NPs for animal experiment
Previous studies showed that NPs are tend to agglomer-
ate when dispersed in medium and agglomerations are
accelerated in high salt conditions such as PBS and sa-
line [34]. Therefore, we used serum protein as a disper-
sion medium to provide protein corona formation,
which can improve dispersion of NPs in physiological
condition as previously described [34]. Briefly, the stock
solution of NiO NPs was prepared by dispersion at
4000 cm2/mL (4360 μg/mL) in DW. The solution was
sonicated for 10 min using a bath sonicator (Saehan-
Sonic, Seoul, Korea) and heat-inactivated rat serum col-
lected from healthy 6-week old female Wistar rats (Sam-
tako, Gyeonggi-do, Korea) was added at 3 % of end
concentration and sonicated for 5 min. Finally, Ca2+-
and Mg2+-free PBS (Life Technologies, Gaithersburg,
MD, USA) was added to the NP suspension to achieve
pre-determined final concentrations (100, 200, and
400 cm2/mL) for animal experimentation, followed by
sonication for 5 min in a bath sonicator (Saehan-Sonic).
Intratracheal instillation of NiO NPs
Animal protocols were reviewed and approved by the In-
stitutional Animal Care and Use Committee in Dong-A
University. Six-week old female Wistar rats (Samtako)
were acclimatized for 7 days before experimentation.
Rats were housed in an individually ventilated cage sys-
tem with controlled temperature and humidity (22 ± 1 °
C and 50 ± 10 %) with a 12 h light/dark cycle. NiO NP
suspensions were intratracheally instilled into the lungs
of rats at surface area doses of 50, 100, and 200 cm2/rat
(54.5, 109, and 218 μg/rat) according to the previously
described method [8]. Briefly, rats were anesthetized by
isoflurane inhalation (Piramal Critical Care, Bethlehem,
PA, USA) using a rodent anesthesia system (VetEquip,
Pleasanton, CA, USA), and intubated with a 16-gauge
blunt polycarbonate catheter. Then 500 μL of NP sus-
pension or vehicle control (PBS with 3 % rat serum) was
instilled once using a sterile syringe.
OVA-induced allergic airway inflammation model
As a positive control for IgE-mediated allergic inflamma-
tion, the OVA-induced allergic airway inflammation
model was established according to the previously
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described method, with slight modification [35]. Briefly,
6-week old female Wistar rats were sensitized on days 0,
7, and 14 with an intraperitoneal injection of 1 mg OVA
(Grade V, Sigma-Aldrich, St Louis, MO, USA) and
100 mg aluminum hydroxide (Sigma-Aldrich) in 1 mL
sterile saline. On day 21, rats were challenged with 1 mg
OVA by intratracheal instillation and then sacrificed on
day 22 to collect the BALF and serum.
Intratracheal instillation of nickel ion (NiCl2)
Because we hypothesized that NiO NPs can produce eo-
sinophilia via the accumulation of nickel ions in the pha-
golysosomes of phagocytes, NiCl2 were instilled into
lungs of rats to demonstrate the direct effect of nickel
ions. Our previous studies also showed that instillation
CoCl2 and ZnCl2 produced similar magnitude of eosino-
philia as observed in CoO and ZnO at an equal metal
concentrations [8, 11]. Although NiO NPs in the lung
might not completely dissolved in the lung within 3 days
after instillation, we selected the dose of NiCl2 at
378.0 μg/rat (171.1 μg Ni/rat), which is equivalent nickel
concentration of 200 cm2/rat of NiO NPs to evaluate
whether the dissolved nickel from NiO NPs directly in-
duce pulmonary eosinophilia or not. NiCl2 (Sigma-Al-
drich) dissolved in sterile Ca2+- and Mg2+-free PBS (Life
Technologies) was intratracheally instilled into the lungs
of rats and then sacrificed at 24 h post-instillation to col-
lect the BALF and serum.
Preparation of BALF
At each time point, rats were anesthetized by isoflurane
inhalation (Piramal Critical Care) and euthanized by re-
moving blood from the inferior vena cava. The trachea
was then cannulated by 14-gauge blunt stainless-steel
needle and lavaged in-situ with 8 mL sterile cold Ca2+-
and Mg2+-free PBS (Life Technologies) 4 times. The re-
covery volumes of the first lavage were about 7 mL and
the subsequent lavages were about 8 mL. The first lavage
was collected separately, and the cell-free supernatant
was kept at −70 °C for further assays. Cell pellets from 4
lavages were pooled for total cell counts and cytological
evaluation. The total number of cells was counted using
a NucleoCounter (Chemometec, Allerod, Denmark); 4 ×
104 cells were attached to glass slides by spinning at 27 g
for 5 min using a cytospin (Hanil, Seoul, Korea). Slides
were then dried, fixed with 100 % methanol, and stained
with Diff-Quik (Thermo Fisher Scientific, Waltham,
MA, USA). Differential cell counting was performed
under a light microscope based on the morphology of
cells. A minimum of 300 cells per slide was counted.
Measurement of nickel levels in BALF
The levels of nickel in BALF were measured to under-
stand the uptake and dissolution of NiO NPs in the lung.
The cell-free first lavage was centrifuged at 15000 g for
30 min to collect NP-free supernatant. Then, the con-
centration of dissolved nickel ions in the supernatant
was measured using inductively coupled mass spectrom-
etry (ICP-MS; Agilent Technologies).
Measurement of LDH, total protein, and pro-inflammatory
cytokines in BALF
The levels of LDH, a maker for cytotoxicity, were mea-
sured in BALF using an LDH assay kit (Roche Diagnos-
tics, Mannheim, Germany). Total protein, a maker for
vascular permeability, was measured in BALF using a
bicinchoninic acid (BCA) assay kit (Thermo Fisher Sci-
entific). To evaluate the underlying mechanism of in-
flammation by NiO NPs, pro-inflammatory cytokines
related to acute neutrophilic inflammation (IL-1β and
CINC-3), eosinophilic inflammation (eotaxin and IL-4),
and Th1 response (IFN-γ) were measured in BALF using
a Duoset enzyme-linked immunosorbent assay (ELISA)
kit (all from R&D systems, Minneapolis, MN, USA).
Measurement of total IgE, C3a, and C5a in BALF and
serum
To evaluate the mechanism of allergic lung inflamma-
tion, the level of total IgE was measured in BALF and
serum using an ELISA kit (Komabiotech, Seoul, Korea)
according to the manufacturer’s instruction. The levels
of C3a and C5a, marker for complement activation, were
measured in BALF and serum using a C3a ELISA kit
(MBS2503333, MyBioSource, San Diego, CA, USA) and
C5a ELISA kit (MBS2506864, MyBioSource).
Measurement of intracellular eotaxin in alveolar
macrophages and normal lung tissue
To evaluate whether the direct lysis of cells can release
intracellular eotaxin, the levels of eotaxin were measured
using alveolar macrophages and normal lung tissue be-
fore and after addition of cell lysis buffer. To collect the
alveolar macrophages, 6-week old female Wistar rats
(Samtako) were sacrificed and lungs were lavaged 4
times with 8 mL of PBS and cell pellets were collected
by simple centrifugation and suspended with 1 mL of
PBS. The number of total cells was counted using a
NucleoCounter (Chemometec) and cytospin slides were
prepared to confirm that more than 99 % of cells in
BALF are alveolar macrophages. Then, cell lysis buffer
(Atto, Tokyo, Japan) was added at a volume of 1 mL for
1 × 107 cells. To evaluate the dose–response relationship,
the cells were lysed at different concentrations of cell
lysis buffer by serial dilution with PBS. On the other
hand, normal lung tissue was collected from 6-week old
female Wistar rats (Samtako) and homogenized using
tissue homogenizer. Then, cell lysis buffer (Atto) was
added at a volume of 1 mL for 50 mg of lung tissue. Cell
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lysis buffer was serially diluted with PBS to evaluate the
dose–response relationship. Alveolar macrophages and
tissue homogenates were incubated with cell lysis buffer
for 30 min and cell-free supernatants were collected by
centrifugation at 500 g for 5 min followed by centrifuga-
tion at 15000 g for 5 min. The levels of LDH and eotaxin
levels were then measured using a LDH assay kit (Roche
Diagnostics) and a Duoset ELISA kit (R&D systems),
respectively.
Statistical analysis
Number of rats for NiO NPs was 10 per group, while the
number of rats for NiCl2 and OVA-induced airway inflam-
mation group was 4 per group. One-way analysis of vari-
ance (ANOVA) was applied to the data having more than
3 groups, while the unpaired student’s t-test was applied
to the OVA-induced airway inflammation group and
NiCl2 treated group. When ANOVA test showed statis-
tical significance (p < 0.05), each group was compared
using post-hoc Tukey’s pairwise comparisons. Pearson
correlation test was applied to evaluate the correlation be-
tween the levels of LDH and eotaxin in cell lysis experi-
ment. All statistical analysis and graphs were prepared
using GraphPad Prism (version 6.0 for Windows; Graph-
Pad Software, San Diego, CA, USA). A value of p < 0.05
was considered statistically significant.
Additional file
Additional file 1: Figure S1. Transmission electron microscopy (TEM)
and field emission-type scanning electron microscopy (FE-SEM) image of
NiO NPs. (A) TEM. (B) FE-SEM. Figure S2. Cytological analysis of BALF after
intratracheal instillation of NiO NPs. NiO NPs were instilled at 50 and 100
cm2/rat and cytological evaluation was performed at 1, 2, 3, and 4 days
after instillation. (A), Number of total cells. (B) Number of macrophages.
(C) Number of neutrophils. (D) Number of eosinophils. Mean ± SEM
(n = 4). One-way ANOVA test was applied for comparison between NiO
NPs and vehicle control (VEH) with statistical significance indicated by
*p < 0.05, **p < 0.01, and ***p < 0.001. Figure S3. The levels of nickel (Ni) in
BALF at 1, 2, 3, and 4 days after intratracheal instillation of NiO NPs at 200
cm2/rat. Mean ± SEM (n = 4). One-way ANOVA test was applied for
comparison between NiO NPs and vehicle control (VEH) with statistical
significance indicated by *p < 0.05 and **p < 0.01. Figure S4. Levels of
lactate dehydrogenase (LDH) and total protein in BALF treated with NiO
NPs. NiO NPs were instilled at 50 and 100 cm2/rat and the levels of LDH
and total protein were measured at 1, 2, 3, and 4 days after instillation.
(A), Levels of LDH. (B), Levels of total protein. Mean ± SEM (n = 4).
One-way ANOVA test was applied for comparison between NiO NPs and
vehicle control (VEH) with statistical significance indicated by ***p < 0.001.
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